Target intelligence / Profile preview

High mobility group box 1 pseudogene 50 (HMGB1P50)

Target
HMGB1P50
Molecular classification
Pseudogene, Processed pseudogene
01

Overview

High mobility group box 1 pseudogene 50 (HMGB1P50) is a predicted processed pseudogene related to the high mobility group box 1 (HMGB1) protein family. Pseudogenes, including those related to HMGB1, commonly result from gene duplication or retrotransposition events and do not typically encode functional proteins. Some pseudogenes are transcribed and may indirectly regulate their parental gene by acting as competitive endogenous RNAs (ceRNAs) or miRNA decoys, but there is no evidence that HMGB1P50 has such a role. HMGB1P50 is not considered a receptor, enzyme, transporter, or functional therapeutic target. There is no documented role for HMGB1P50 in disease, nor are there any drugs known to interact with it. The designation "HMGB1P50" is likely a database identifier used to mark its sequence relationship to HMGB1, rather than a name for a biologically active entity. If explicit functional, clinical, or therapeutic attributes of HMGB1P50 are required, further research or experimental evidence would be necessary. Currently, it is best categorized as a non-functional genomic pseudogene, and not a validated target for drug discovery or biomarker usage.

Other names
HMGB1P50
02

Biological functions

No direct biological function has been reported for this specific pseudogene.Generally, pseudogenes can act as miRNA decoys or regulators of their parental gene transcripts, but this has not been demonstrated for HMGB1P50.
03

Disease associations

None reported for HMGB1P50.Parent gene HMGB1 has been implicated in cancer, inflammation, and other conditions, but such roles have not been documented for this pseudogene.

Beyond the preview

Go deeper on High mobility group box 1 pseudogene 50 (HMGB1P50).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 1 pseudogene 50 (HMGB1P50).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call